Cellular Mechanisms of High Mobility Group 1 (HMGB-1) Protein Action in the Diabetic Retinopathy

Involvement of HMGB1 mediated signalling pathway in diabetic retinopathy: evidence from type 2 diabetic rats and ARPE-19 cells under diabetic condition

(2013) Xiao-Li Chen et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina

(2012) Ghulam Mohammad et al.   EXPERIMENTAL EYE RESEARCH

Diabetic Retinopathy

(2012) David A. Antonetti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Induction of Ischemic Tolerance Protects the Retina From Diabetic Retinopathy

(2011) Diego C. Fernandez et al.   AMERICAN JOURNAL OF PATHOLOGY

High-Mobility Group Box-1 Mediates Toll-Like Receptor 4–Dependent Angiogenesis

(2011) Qing Lin et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Leukocyte Adhesion Molecules in Diabetic Retinopathy

(2011) Kousuke Noda et al.   Journal of Ophthalmology

HMGB1 and RAGE in Inflammation and Cancer

(2010) Gary P. Sims et al.   Annual Review of Immunology

High-Mobility Group Box-1 Protein Promotes Angiogenesis After Peripheral Ischemia in Diabetic Mice Through a VEGF-Dependent Mechanism

(2010) F. Biscetti et al.   DIABETES

Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1)

(2008) Judy R. van Beijnum et al.   ANGIOGENESIS

Differential gene expression profiling of large and small retinal ganglion cells

(2008) Dmitry Ivanov et al.   JOURNAL OF NEUROSCIENCE METHODS

Direct labeling and visualization of blood vessels with lipophilic carbocyanine dye DiI

(2008) Yiwen Li et al.   Nature Protocols